Neurocognition, Insight and Medication Nonadherence in Schizophrenia: A Structural Equation Modeling Approach

Abstract

ObjectiveThe aim of this study was to examine the complex relationships among neurocognition, insight and nonadherence in patients with schizophrenia.Methods Design: Cross-sectional study. Inclusion criteria: Diagnosis of schizophrenia according to the DSM-IV-TR criteria. Data collection: Neurocognition was assessed using a global approach that addressed memory, attention, and executive functions; insight was analyzed using the multidimensional ‘Scale to assess Unawareness of Mental Disorder;’ and nonadherence was measured using the multidimensional ‘Medication Adherence Rating Scale.’ Analysis: Structural equation modeling (SEM) was applied to examine the non-straightforward relationships among the following latent variables: neurocognition, ‘awareness of positive symptoms’ and ‘negative symptoms’, ‘awareness of mental disorder’ and nonadherence.ResultsOne hundred and sixty-nine patients were enrolled. The final testing model showed good fit, with normed χ2 = 1.67, RMSEA = 0.063, CFI = 0.94, and SRMR = 0.092. The SEM revealed significant associations between (1) neurocognition and ‘awareness of symptoms,’ (2) ‘awareness of symptoms’ and ‘awareness of mental disorder’ and (3) ‘awareness of mental disorder’ and nonadherence, mainly in the ‘attitude toward taking medication’ dimension. In contrast, there were no significant links between neurocognition and nonadherence, neurocognition and ‘awareness of mental disorder,’ and ‘awareness of symptoms’ and nonadherence.ConclusionsOur findings support the hypothesis that neurocognition influences ‘awareness of symptoms,’ which must be integrated into a higher level of insight (i.e., the ‘awareness of mental disorder’) to have an impact on nonadherence. These findings have important implications for the development of effective strategies to enhance medication adherence.

Decreasing self-reported cognitive biases and increasing clinical insight through meta-cognitive training in patients with chronic schizophrenia

“…This is clinically relevant, as a vast majority of chronic patients with schizophrenia tend to exhibit a relatively low level of clinical insight and thus often do not seek optimal treatment (e.g. Boyer et al, 2012).…”

The relationships between patients’ and caregivers’ beliefs about the causes of schizophrenia and clinical outcomes in Latin American countries

“…Future studies should explore the reciprocal relations between patients' and caregivers' beliefs, and their impact on clinical outcomes. This may be done, for example, by using techniques such as structural equation modeling (Boyer, et al, 2012) to directly estimate the simultaneous and synergic impact of patients' and caregivers' beliefs on clinical outcomes (Falissard, 2005)…”

Insight in Schizophrenia: Relationship to Positive, Negative and Neurocognitive Dimensions

“…[64] Apart from psychoeducating the families, interventions which focus on the improvement in insight and amelioration of cognitive impairments is essential. Recent models of treatment, targeting metacognitive deficits in psychosis might provide greater “insights” into therapy aiming at changing “insight” in schizophrenia, thus improving the adherence to treatment.…”